-
China has 45 rare disease drugs included in the national medical insurance drug list, covering 26 rare diseases
Time of Update: 2022-11-14
js?cdnversion='+~(-new Date()/36e5)];According to Chinese state media reports on November 3, China's national medical insurance drug catalogue will be adjusted in 2022, opening a separate declaration channel for rare disease drugs to support their priority entry into the medical insurance drug catalogue.
-
Pharmaceutical advertising is again strictly regulated! Celebrities are not allowed to endorse pharmaceutical products!
Time of Update: 2022-11-14
The Interim Measures for the Review and Administration of Advertisements for Drugs, Medical Devices, Health Foods, and Formula Foods for Special Medical Purposes were formulated and promulgated by the State Administration for Market Regulation and came into force in March 2020; The Advertising Law of the People's Republic of China was amended for the second time in April 2021; .
-
The national medical security directly settles public service information for cross-provincial medical treatment
Time of Update: 2022-11-14
In September, 3,376,800 outpatient expenses were settled across provinces nationwide, involving medical expenses of 828 million yuan, and fund payments were 490 million yuan, an increase of 5.
-
Announcement of the State Food and Drug Administration on amending the instructions of liver hydrolyzed peptide injection
Time of Update: 2022-11-14
According to the results of adverse drug reaction assessment, in order to further protect the safety of public drug use, the State Medical Products Administration decided to uniformly revise the instructions of liver hydrolyzed peptide injections (including liver hydrolyzed peptide injection and liver hydrolyzed peptides for injection).
-
High temperature has reduced citrus production, and the tangerine peel market is expected to continue to rise!
Time of Update: 2022-11-14
Tangerine peel, is a variety with large demand but low attention, the early market is basically below 5 yuan, in 2021 due to the reduction of production market rise, in 2022 after the new market not only does not go down, the price has a further trend of higher.
-
Announcement on the Implementation of Electronic Declaration of Drug Registration Applications (Draft for Solicitation of Comments)
Time of Update: 2022-11-14
In order to implement the reform requirements of "decentralization, management and service", further optimize the business environment, reduce the burden on enterprises, and promote the electronic de
-
Announcement on Re-registration and Administration of Chemical APIs (Draft for Solicitation of Comments)
Time of Update: 2022-11-14
2. Drafting notes "Announcement on the Re-registration and Administration of Chemical APIs and Other Related Matters (Draft for Comments)" feedback form of the Comprehensive Department of the State Food and Drug Administration November 2, 2022 ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
-
The National Health Commission issued the standards for setting the National Laboratory Medicine Center
Time of Update: 2022-11-14
Health Commissions of all provinces, autonomous regions, municipalities directly under the Central Government and the Xinjiang Production and Construction Corps: In order to implement the decisions a
-
Five-year covenant "Innovation and mutual trust" Novartis brings a number of blockbuster innovative products and industry-leading products
Time of Update: 2022-11-13
At this year's CIIE, Novartis focused on displaying a number of innovative drugs for cardiovascular, immunological, oncology, ophthalmology, central nervous system and other core therapeutic fields, including Noxinto, Keshanting ® ®, Nordage ®, Zhaole ®, Gleevec ® and other blockbuster products that won the Galen Award.
-
The joint procurement of traditional Chinese medicine pieces has started, and the upstream processing equipment industry may be affected
Time of Update: 2022-11-11
The industry believes that joint procurement will affect several aspects of Chinese medicine pieces manufacturers, including quality, supply and price, in addition to ensuring supply, in terms of price and quality, in fact, controlling costs and improving the quality of pieces are challenges that future pieces enterprises have to face.
-
The pharmaceutical sector moved, and many individual stocks such as Zhongsheng Pharmaceutical and Lingkang Pharmaceutical rose and stopped
Time of Update: 2022-11-11
Kangchen Pharmaceutical: 4 ups and downs in the past year As of 11:00 on November 4, Kangchen Pharmaceutical is also in a state of up and down, the stock is quoted at 28.
-
The traditional Chinese medicine sector has changed, and many stocks such as Special One Pharmaceutical and Zhongsheng Pharmaceutical have risen and stopped
Time of Update: 2022-11-11
【Pharmaceutical Network Pharmaceutical Stock Market】On November 9, the traditional Chinese medicine sector changed, and individual stocks were up and down, including many stocks such as Special One Ph
-
Local pharmaceutical companies are vigorously building production bases, and the pharmaceutical machinery industry may usher in new opportunities
Time of Update: 2022-11-11
In general, from the current trend of industry development, pharmaceutical companies have become the norm in the industry to expand their production capacity by choosing to build and acquire production bases.
-
At the end of the third quarterly report, what kind of "answer sheet" did pharmaceutical equipment companies hand over?
Time of Update: 2022-11-11
【Pharmaceutical Network Market Analysis】A few days ago, the third quarterly report of listed pharmaceutical equipment companies in 2022 has basically ended, and the overall performance is stable and good, of which the operating income and net profit of the first three quarters represented by Chutian Technology, Dongfulong and other leading enterprises have achieved year-on-year growth.
-
Under multiple benefits, the pharmaceutical sector in the future market may usher in an inflection point!
Time of Update: 2022-11-11
Looking forward to the future market, Huaxia Fund believes that with the steady growth of medical insurance expenditure, the recovery of innovative drug policies and the rationalization of centralized procurement policies, the marginal changes in the industry have changed.
-
In the first 10 months, China's exports increased by 13% year-on-year, how did the pharmaceutical equipment industry perform?
Time of Update: 2022-11-11
【Pharmaceutical Network Market Analysis】On November 7, the General Administration of Customs released data showing that in the first 10 months of this year, China's total import and export value was 3
-
The Chinese medicine sector soared 26% in a month! The main line of development in the fourth quarter is optimistic
Time of Update: 2022-11-11
【Pharmaceutical Network Market Analysis】 Chinese medicine refers to the medicinal materials used to prevent and treat diseases guided by the theory of Chinese medicine, usually including natural medic
-
The long-term development of the pharmaceutical sector is optimistic, and these four subdivisions are worth paying attention to!
Time of Update: 2022-11-11
It is worth noting that up to now, dozens of multinational pharmaceutical and medical device companies have announced new actions in China at the fifth CIIE, including direct investment, cooperation with local enterprises, and localized production.
-
Innovative drug research and development is difficult, and the research and development of first-in-class cannot be blind
Time of Update: 2022-11-11
According to the FDA's definition, a drug granted first-in-class designation refers to a drug that uses a completely new and unique mechanism of action to treat a certain disease 。 In recent years, wi
-
In less than a month, many pharmaceutical stocks rose by more than 60%
Time of Update: 2022-11-11
The market performance of the microelectrophysiology-U range is also very eye-catching, rising as much as 110% in October, and as of the close of November 7, the stock was quoted at 27.
